Article ; Online: In silico assessment of genotoxicity. Combinations of sensitive structural alerts minimize false negative predictions for all genotoxicity endpoints and can single out chemicals for which experimentation can be avoided.
Regulatory toxicology and pharmacology : RTP
2021 Volume 126, Page(s) 105042
Abstract: Genotoxicity assessment of chemicals has a crucial role in most regulations. Due to labor, time, cost, and animal welfare issues, attention is being given to (Q)SAR methods. A strategic application of alternative methods is to first use a sequence of ... ...
Abstract | Genotoxicity assessment of chemicals has a crucial role in most regulations. Due to labor, time, cost, and animal welfare issues, attention is being given to (Q)SAR methods. A strategic application of alternative methods is to first use a sequence of conservative (very sensitive) (Q)SARs and/or in vitro models to arrive at the conclusion that no further testing is necessary for negatives, and to use mechanistically based, Weight-Of-Evidence approach to evaluate the chemicals showing positive results. The ICH M7 guideline to detect DNA-reactive impurities in drugs follows these lines (recommending solely (Q)SAR in step 1). However, ICH M7 focuses only on Ames test. Here a large database of more than 6000 chemicals positive in at least one endpoint (in vitro gene mutations or chromosomal aberrations, in vivo micronucleus, aneugenicity) were analyzed with structural alerts implemented in the OECD QSAR Toolbox, resulting in maximum 3% false negatives. These promising results indicate that it may be possible to extend the approach to the whole range of genotoxicity endpoints required by regulations. Since structural alerts may generate false positives, cautious follow-up of positives is recommended (with e.g., statistically based QSARs, read across of similar chemicals, expert judgement, and experimentation when necessary). |
---|---|
MeSH term(s) | Animal Welfare ; Computational Chemistry/methods ; Computational Chemistry/standards ; Cost-Benefit Analysis ; Databases, Factual ; Drug-Related Side Effects and Adverse Reactions/diagnosis ; False Negative Reactions ; Mutagenicity Tests/standards ; Pharmaceutical Preparations/chemistry ; Quantitative Structure-Activity Relationship ; Time Factors |
Chemical Substances | Pharmaceutical Preparations |
Language | English |
Publishing date | 2021-09-08 |
Publishing country | Netherlands |
Document type | Journal Article |
ZDB-ID | 604672-1 |
ISSN | 1096-0295 ; 0273-2300 |
ISSN (online) | 1096-0295 |
ISSN | 0273-2300 |
DOI | 10.1016/j.yrtph.2021.105042 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1711: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.